SPINE
Local bone and hydroxyapatite graft versus ICBG for transforaminal lumbar interbody fusion
Eur Spine J. 2017 Nov;26(11):2835-284250 patients scheduled for transforaminal lumbar interbody fusion due to degenerative lumbar disease between L1 and S2 were included in this study to compare outcomes between different bone grafting materials. Patients were randomized to receive an autologous iliac crest bone graft or a mixture of hydroxyapatite combined with autologous bone from decompression sites. Fusion and clinical outcomes were measured over a 12-month follow-up. The fusion rate was similar between the different bone grafting materials at 12 months, both reporting an 83% fusion rate based on CT criteria. Both groups demonstrated significant improvements in VAS pain and disability (ODI), however, there were no differences between groups.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
